Announced
Completed
SOBI completed the acquisition of a 60% stake in Pint Pharma International from Farallon Capital-backed Pintador for $105m.
Synopsis
SOBI, a biopharmaceutical and biotechnology company, completed the acquisition of a 60% stake in Pint Pharma International, a biopharmaceutical company, from Farallon Capital-backed Pintador, a holding company, $105m.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2026 Datasite